Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-12

Clinical Trial Update: MGR001 / Advair Diskus Local Equivalence Study in Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial update for MGR001/Advair Diskus local equivalence study in asthma has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADVAIR DISKUS (fluticasone propionate and salmeterol)
  • MGR001

Snippet

Sponsor: Mylan Pharma UK Ltd. | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2021-01-12